In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group
Lifestyle modification including dietary changes and physical activity is essential alongside retatrutide
Foam or bubbles Some foaming during reconstitution is normal and resolves as the solution settles
If it doesnt, see your GP about testing your blood sugar or hormone levels
while erasing pain, fatigue and blood-sugar issues An astonishing fact about the GLP-1 meds that are helping millions lose weight: Tirzepatide, the active ingredient in Mounjaro and Zepbound, has the power to stop prediabetes in its tracks for 99 percent of us, per a study in the New England Journal of Medicine
Ready to start your weight loss journey with expert medical guidance and individualized support